BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 33785874)

  • 1. 5-Aminosalicylic acid inhibits stem cell function in human adenoma-derived cells: implications for chemoprophylaxis in colorectal tumorigenesis.
    Dixon SW; Collard TJ; Mortensson EMH; Legge DN; Chambers AC; Greenhough A; Creed TJ; Williams AC
    Br J Cancer; 2021 Jun; 124(12):1959-1969. PubMed ID: 33785874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of 5-aminosalicylic acid on the progression of colorectal adenomas via the β-catenin signaling pathway.
    Munding J; Ziebarth W; Pox CP; Ladigan S; Reiser M; Hüppe D; Brand L; Schmiegel W; Tannapfel A; Reinacher-Schick AC
    Carcinogenesis; 2012 Mar; 33(3):637-43. PubMed ID: 22198215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LGR5 promotes survival in human colorectal adenoma cells and is upregulated by PGE2: implications for targeting adenoma stem cells with NSAIDs.
    Al-Kharusi MR; Smartt HJ; Greenhough A; Collard TJ; Emery ED; Williams AC; Paraskeva C
    Carcinogenesis; 2013 May; 34(5):1150-7. PubMed ID: 23349017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CBB1003, a lysine-specific demethylase 1 inhibitor, suppresses colorectal cancer cells growth through down-regulation of leucine-rich repeat-containing G-protein-coupled receptor 5 expression.
    Hsu HC; Liu YS; Tseng KC; Yang TS; Yeh CY; You JF; Hung HY; Chen SJ; Chen HC
    J Cancer Res Clin Oncol; 2015 Jan; 141(1):11-21. PubMed ID: 25060070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of chemoprevention of colorectal cancer with 5-aminosalicylates in ulcerative colitis.
    Herfarth H
    Dig Dis; 2012; 30 Suppl 2():55-9. PubMed ID: 23207933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence.
    Chell SD; Witherden IR; Dobson RR; Moorghen M; Herman AA; Qualtrough D; Williams AC; Paraskeva C
    Cancer Res; 2006 Mar; 66(6):3106-13. PubMed ID: 16540660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CPT2 downregulation triggers stemness and oxaliplatin resistance in colorectal cancer via activating the ROS/Wnt/β-catenin-induced glycolytic metabolism.
    Li H; Chen J; Liu J; Lai Y; Huang S; Zheng L; Fan N
    Exp Cell Res; 2021 Dec; 409(1):112892. PubMed ID: 34688609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Expression of Stem Cell Marker LGR5 and Its Coexpression with Β-Catenin in Sporadic Colorectal Carcinoma and Adenoma: A Comparative Immunohistochemical Study.
    Ahmed EM; Farag AS; Abdelwahed MS; Hanbazazh M; Samman A; Ashmawy D; Abd-Elhameed NR; Tharwat M; Othman AE; Shawky TA; Attia RM; Ibrahim AA; Azzam S; Elhussiny MEA; Nasr M; Naeem SA; Abd-Elhay WM; Ali Alfaifi AM; Hasan A
    Medicina (Kaunas); 2023 Jun; 59(7):. PubMed ID: 37512045
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor beta (TGF-beta): conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-beta.
    Manning AM; Williams AC; Game SM; Paraskeva C
    Oncogene; 1991 Aug; 6(8):1471-6. PubMed ID: 1886718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LGR5 expression is regulated by EGF in early colorectal adenomas and governs EGFR inhibitor sensitivity.
    Morgan RG; Mortensson E; Legge DN; Gupta B; Collard TJ; Greenhough A; Williams AC
    Br J Cancer; 2018 Feb; 118(4):558-565. PubMed ID: 29149105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-30-5p suppresses cell chemoresistance and stemness in colorectal cancer through USP22/Wnt/β-catenin signaling axis.
    Jiang S; Miao D; Wang M; Lv J; Wang Y; Tong J
    J Cell Mol Med; 2019 Jan; 23(1):630-640. PubMed ID: 30338942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UHRF2 promotes intestinal tumorigenesis through stabilization of TCF4 mediated Wnt/β-catenin signaling.
    Li L; Duan Q; Zeng Z; Zhao J; Lu J; Sun J; Zhang J; Siwko S; Wong J; Shi T; Zhang X; Liu M; Chen J; Li D
    Int J Cancer; 2020 Oct; 147(8):2239-2252. PubMed ID: 32372448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA CCAL regulates colorectal cancer progression by activating Wnt/β-catenin signalling pathway via suppression of activator protein 2α.
    Ma Y; Yang Y; Wang F; Moyer MP; Wei Q; Zhang P; Yang Z; Liu W; Zhang H; Chen N; Wang H; Wang H; Qin H
    Gut; 2016 Sep; 65(9):1494-504. PubMed ID: 25994219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential pre-malignant programs and microenvironment chart distinct paths to malignancy in human colorectal polyps.
    Chen B; Scurrah CR; McKinley ET; Simmons AJ; Ramirez-Solano MA; Zhu X; Markham NO; Heiser CN; Vega PN; Rolong A; Kim H; Sheng Q; Drewes JL; Zhou Y; Southard-Smith AN; Xu Y; Ro J; Jones AL; Revetta F; Berry LD; Niitsu H; Islam M; Pelka K; Hofree M; Chen JH; Sarkizova S; Ng K; Giannakis M; Boland GM; Aguirre AJ; Anderson AC; Rozenblatt-Rosen O; Regev A; Hacohen N; Kawasaki K; Sato T; Goettel JA; Grady WM; Zheng W; Washington MK; Cai Q; Sears CL; Goldenring JR; Franklin JL; Su T; Huh WJ; Vandekar S; Roland JT; Liu Q; Coffey RJ; Shrubsole MJ; Lau KS
    Cell; 2021 Dec; 184(26):6262-6280.e26. PubMed ID: 34910928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEK inhibitors activate Wnt signalling and induce stem cell plasticity in colorectal cancer.
    Zhan T; Ambrosi G; Wandmacher AM; Rauscher B; Betge J; Rindtorff N; Häussler RS; Hinsenkamp I; Bamberg L; Hessling B; Müller-Decker K; Erdmann G; Burgermeister E; Ebert MP; Boutros M
    Nat Commun; 2019 May; 10(1):2197. PubMed ID: 31097693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Long-Term Mesalamine Therapy on Cancer-Associated Gene Expression in Colonic Mucosa of Patients with Ulcerative Colitis.
    Bajpai M; Seril DN; Van Gurp J; Geng X; Alvarez J; Minacapelli CD; Gorin S; Das KK; Poplin E; Cheng J; Amenta PS; Das KM
    Dig Dis Sci; 2019 Mar; 64(3):740-750. PubMed ID: 30478770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
    Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J
    Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesalamine modulates intercellular adhesion through inhibition of p-21 activated kinase-1.
    Khare V; Lyakhovich A; Dammann K; Lang M; Borgmann M; Tichy B; Pospisilova S; Luciani G; Campregher C; Evstatiev R; Pflueger M; Hundsberger H; Gasche C
    Biochem Pharmacol; 2013 Jan; 85(2):234-44. PubMed ID: 23146664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of disrupted pathways in ulcerative colitis-related colorectal carcinoma by systematic tracking the dysregulated modules.
    Wu D; Li Q; Song G; Lu J
    J BUON; 2016; 21(2):366-74. PubMed ID: 27273946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.